Cell polarity (the 'four lines') distinguishes gastric dysplasia from epithelial changes in reactive gastropathy.


Journal

Histopathology
ISSN: 1365-2559
Titre abrégé: Histopathology
Pays: England
ID NLM: 7704136

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 22 06 2020
revised: 06 08 2020
accepted: 19 08 2020
pubmed: 26 8 2020
medline: 3 11 2021
entrez: 26 8 2020
Statut: ppublish

Résumé

Gastric dysplasia is a risk factor for synchronous and subsequent gastric carcinoma. Distinguishing gastric dysplasia from reactive changes is subject to interobserver disagreement and is a frequent reason for expert consultation. We previously used assessment of surface cell polarity (the 'four lines') as a key feature to decrease equivocal diagnoses in Barrett oesophagus. In the current study, we examined for the presence or absence of the four lines in gastric dysplasia and reactive gastropathy. The study includes all (n = 91) in-house biopsies with at least gastric dysplasia from the surgical pathology archives of two academic institutions during a 5-year period from 2008 to 2012. A reactive gastropathy group (n = 60) was created for comparison. The dysplasia/neoplasia group was comprised of 14 biopsies of gastric foveolar-type dysplasia, 59 of intestinal-type dysplasia, 14 with dysplasia in fundic gland polyps, three pyloric gland adenomas and one oxyntic gland adenoma. Loss of surface cell polarity was seen in all 88 dysplasia cases with evaluable surface epithelium. All 57 reactive gastropathy cases with evaluable surface epithelium showed intact surface cell polarity except in focal areas directly adjacent to erosions in 17 cases, where the thin wisp of residual surface mucin could not be appreciated on haematoxylin and eosin. Surface cell polarity (the four lines) was lost in all gastric dysplasia biopsies with evaluable surface epithelium and maintained in all biopsies of reactive gastropathy. Caution should be taken in using this feature adjacent to erosions in reactive gastropathy.

Identifiants

pubmed: 32841414
doi: 10.1111/his.14242
pmc: PMC9281539
mid: NIHMS1820779
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

453-458

Subventions

Organisme : NCI NIH HHS
ID : T32 CA193145
Pays : United States

Informations de copyright

© 2020 John Wiley & Sons Ltd.

Références

Am J Gastroenterol. 1993 Oct;88(10):1714-9
pubmed: 8213713
Gastroenterol Clin North Am. 2013 Jun;42(2):211-7
pubmed: 23639637
Am J Surg Pathol. 2012 Jul;36(7):1030-5
pubmed: 22472957
Virchows Arch. 2003 Apr;442(4):317-21
pubmed: 12715167
Gut. 2019 Sep;68(9):1545-1575
pubmed: 31278206
Am J Surg Pathol. 2014 Nov;38(11):1545-50
pubmed: 25310837
Am J Surg Pathol. 2002 Oct;26(10):1276-85
pubmed: 12360042
Am J Surg Pathol. 2018 Dec;42(12):1723-1729
pubmed: 30234520
Endoscopy. 2019 Apr;51(4):365-388
pubmed: 30841008
Gastroenterology. 2020 Feb;158(3):693-702
pubmed: 31816298
Gut. 2000 Aug;47(2):251-5
pubmed: 10896917
Am J Surg Pathol. 2009 Feb;33(2):186-93
pubmed: 18830123
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Gastroenterology. 2008 Apr;134(4):945-52
pubmed: 18395075
Am J Surg Pathol. 2011 Jul;35(7):1021-9
pubmed: 21677540
Am J Surg Pathol. 1987 Oct;11(10):788-96
pubmed: 3661823
Pathology. 2017 Jun;49(4):391-396
pubmed: 28438394
Gastroenterology. 2017 Feb;152(3):564-570.e4
pubmed: 27818167
Histopathology. 2016 May;68(6):843-9
pubmed: 26336971
Korean J Intern Med. 2016 Mar;31(2):201-9
pubmed: 26932397
Gut. 2003 Aug;52(8):1111-6
pubmed: 12865267
Am J Surg Pathol. 2001 Apr;25(4):500-7
pubmed: 11257625
Am J Gastroenterol. 2000 Dec;95(12):3383-7
pubmed: 11151865
Endoscopy. 2013;45(4):249-56
pubmed: 23533073
Am J Surg Pathol. 2000 Feb;24(2):167-76
pubmed: 10680883
Am J Surg Pathol. 2014 Mar;38(3):389-93
pubmed: 24525509

Auteurs

Kevin M Waters (KM)

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Kevan J Salimian (KJ)

Department of Pathology, Johns Hopkins Hospital, Baltimore, MD, USA.

Naziheh Assarzadegan (N)

Department of Pathology, Johns Hopkins Hospital, Baltimore, MD, USA.

Danielle Hutchings (D)

Department of Pathology, Johns Hopkins Hospital, Baltimore, MD, USA.

Elias P Makhoul (EP)

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Annika L Windon (AL)

Department of Pathology, Johns Hopkins Hospital, Baltimore, MD, USA.

Mary T Wong (MT)

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Lysandra Voltaggio (L)

Department of Pathology, Johns Hopkins Hospital, Baltimore, MD, USA.

Elizabeth A Montgomery (EA)

Department of Pathology, Johns Hopkins Hospital, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH